Hydroxyurea remains effective over the long term among children with sickle cell disease, real-world data suggested. The average time on hydroxyurea was 5 years, with many children on the therapy for ...

Columnist Michelle Harlan, who's currently taking hydroxyurea to treat her sickle beta-zero thalassemia, considers some other ...

Large European cohort data suggest hydroxyurea pregnancy exposure in sickle cell disease is not linked to congenital ...

Machine learning identified RDW and HGB as key predictors of hydroxyurea resistance in polycythemia vera, aiding early identification and treatment adjustment. The PV-AIM study used electronic health ...

Memantine, a long-approved and cost-effective drug used to treat Alzheimer’s disease, could also benefit patients with sickle cell anemia in the future. Initial clinical data from an international ...